Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia.
Hepatitis C virus (HCV) plays a major role in the induction of type II mixed cryoglobulinaemia (MCII). The role of HCV proteins and virus-host interaction in the pathogenesis of MC remains to be defined. To address this issue, we have characterized, in detail, the monoclonal IgM and the viral component of circulating immune complexes in eight patients with HCV-associated MCII. The proportion of HCV-RNA compartmentalized in the cryoprecipitate (CP) varied greatly (10-80% of total HCV-RNA). The complementary determining region (CDR)3 sequences of monoclonal immunoglobulin M (IgM) VH and VK genes were highly homologous to rheumatoid factor and to antibodies against HCV-E2. Furthermore, the CDR3 sequences in some of our MCII patients were highly similar to those described in HCV-positive patients with non-Hodgkin's lymphoma (NHL). From these results, it appears that, as in the case of NHL, the IgM-rheumatoid factor (RF) production in MCII patients is antigen driven, namely by E2. However, the limited number of mutations in VH and VK genes with respect to the germline and their distribution showed that the B-cell response in these cases was prevented from undergoing affinity maturation. Furthermore, in patients with monoclonal IgM and definite compartmentalization of HCV in either CP or supernatant, a highly homogeneous E2-hypervariable region (HVR)1 sequence distribution was found (90-100% identical clones), a feature of the quasispecies frequently associated with an impaired humoral immune response to HCV. These findings suggest that in patients with HCV-associated MCII, maturation of monoclonal B lymphocytes may be blocked in a primitive stage preventing serious damaging effects because of the auto-reactivity of their secreted immunoglobulins.
Venetian Institute of Molecular Medicine (VIMM), Padova, Italy.
S
S
Ferri
F
F
Dal Pero
G
G
Bortoletto
F B
FB
Bianchi
M
M
Lenzi
A
A
Alberti
M
M
Gerotto
D000368:Aged; D000595:Amino Acid Sequence; D000936:Antigen-Antibody Complex / Q000276:immunology*; D022801:Complementarity Determining Regions / Q000235:genetics; D003449:Cryoglobulinemia / Q000150:complications / Q000276:immunology*; D005260:Female; D006526:Hepatitis C / Q000150:complications / Q000276:immunology*; D006801:Humans; D007075:Immunoglobulin M / Q000235:genetics / Q000276:immunology*; D007135:Immunoglobulin Variable Region / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009154:Mutation; D012367:RNA, Viral / Q000032:analysis; D016415:Sequence Alignment; D014759:Viral Envelope Proteins / Q000276:immunology*
D000936:Antigen-Antibody Complex; D022801:Complementarity Determining Regions; D007075:Immunoglobulin M; D007135:Immunoglobulin Variable Region; D012367:RNA, Viral; D014759:Viral Envelope Proteins; C091015:glycoprotein E2, Hepatitis C virus